Matches in SemOpenAlex for { <https://semopenalex.org/work/W156808887> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- W156808887 endingPage "42" @default.
- W156808887 startingPage "133" @default.
- W156808887 abstract "This study was designed to examine the association between adiponectin and C-reactive protein (CRP), interleukin-6 (IL-6) and endothelin-1, (ET-1) and their possible role in prediction of type-2 diabetes and development of diabetes and macrovascular complications. Forty subjects were studied. They were classified into four equal groups: Control, newly diagnosed type-2 diabetes, diabetics with old myocardial infarction (OMI) and acute myocardial infarction (AMI) groups. They were matched for body mass index (BMI), age, and sex. Adiponectin and IL-6 were determined by ELISA technique, CRP was determined by immunonephlometry and ET-1 was determined by radioimmunoassay. Adiponectin was found to be decreased in newly diagnosed diabetics (6.64 +/- 2.3 microg/ml), OMI (4.7 +/- 1.05 microg/ml) and AMI (4.23 +/- 0.73 microg/ml) when compared to controls (9.81 +/- 2.2 microg/ml), whereas CRP, IL- 6 and ET-1 were significantly elevated in AMI (18.6 +/- 5.3 mg/l, 12.6 +/- 4.2 pg/ml and 36.8 +/- 10.4 fmol/ml, respectively). The changes were marked in AMI group compared to other diabetic groups. Only adiponectin significantly decreased in newly diagnosed type-2 diabetics, but CRP, IL-6 and ET-1 did not significantly altered in newly diagnosed diabetics (4.9 +/- 1.6 mg/l, 6.9 +/- 2.3 pg/ml and 22.1 +/- 8.6 fmol/ml, respectively) compared to control. Adiponectin correlated negatively with CRP, IL-6 and ET-1, BMI and HbA1c, whereas inflammatory and vascular markers correlated positively with each other and with BMI and HbA1c. In conclusions, adiponectin may be implicated in the development of type-2 diabetes and macrovascular complications and can be used as an early predictor of type-2 diabetes. Whereas, none of the inflammatory and vascular markers can predict diabetes, but can be used as markers of acute vascular events and in follow up of these cases. Immunomodulation of adiponectin may help prevention and treatment of type-2 diabetes and its complications." @default.
- W156808887 created "2016-06-24" @default.
- W156808887 creator A5024172013 @default.
- W156808887 creator A5062569034 @default.
- W156808887 creator A5063901265 @default.
- W156808887 creator A5068878924 @default.
- W156808887 creator A5081513629 @default.
- W156808887 date "2005-01-01" @default.
- W156808887 modified "2023-09-27" @default.
- W156808887 title "Adiponectin and some inflammatory and endothelial markers in type-2 diabetes with and without cardiovascular disease." @default.
- W156808887 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16734148" @default.
- W156808887 hasPublicationYear "2005" @default.
- W156808887 type Work @default.
- W156808887 sameAs 156808887 @default.
- W156808887 citedByCount "1" @default.
- W156808887 crossrefType "journal-article" @default.
- W156808887 hasAuthorship W156808887A5024172013 @default.
- W156808887 hasAuthorship W156808887A5062569034 @default.
- W156808887 hasAuthorship W156808887A5063901265 @default.
- W156808887 hasAuthorship W156808887A5068878924 @default.
- W156808887 hasAuthorship W156808887A5081513629 @default.
- W156808887 hasConcept C126322002 @default.
- W156808887 hasConcept C134018914 @default.
- W156808887 hasConcept C176685330 @default.
- W156808887 hasConcept C2776782570 @default.
- W156808887 hasConcept C2776914184 @default.
- W156808887 hasConcept C2777180221 @default.
- W156808887 hasConcept C2777391703 @default.
- W156808887 hasConcept C2780221984 @default.
- W156808887 hasConcept C2781195455 @default.
- W156808887 hasConcept C500558357 @default.
- W156808887 hasConcept C555293320 @default.
- W156808887 hasConcept C71924100 @default.
- W156808887 hasConcept C90924648 @default.
- W156808887 hasConceptScore W156808887C126322002 @default.
- W156808887 hasConceptScore W156808887C134018914 @default.
- W156808887 hasConceptScore W156808887C176685330 @default.
- W156808887 hasConceptScore W156808887C2776782570 @default.
- W156808887 hasConceptScore W156808887C2776914184 @default.
- W156808887 hasConceptScore W156808887C2777180221 @default.
- W156808887 hasConceptScore W156808887C2777391703 @default.
- W156808887 hasConceptScore W156808887C2780221984 @default.
- W156808887 hasConceptScore W156808887C2781195455 @default.
- W156808887 hasConceptScore W156808887C500558357 @default.
- W156808887 hasConceptScore W156808887C555293320 @default.
- W156808887 hasConceptScore W156808887C71924100 @default.
- W156808887 hasConceptScore W156808887C90924648 @default.
- W156808887 hasIssue "1" @default.
- W156808887 hasLocation W1568088871 @default.
- W156808887 hasOpenAccess W156808887 @default.
- W156808887 hasPrimaryLocation W1568088871 @default.
- W156808887 hasRelatedWork W1503697597 @default.
- W156808887 hasRelatedWork W2049517186 @default.
- W156808887 hasRelatedWork W2068344686 @default.
- W156808887 hasRelatedWork W2188778292 @default.
- W156808887 hasRelatedWork W2348143216 @default.
- W156808887 hasRelatedWork W2353559962 @default.
- W156808887 hasRelatedWork W2354627859 @default.
- W156808887 hasRelatedWork W2360226656 @default.
- W156808887 hasRelatedWork W2362625747 @default.
- W156808887 hasRelatedWork W2384696046 @default.
- W156808887 hasRelatedWork W2387871562 @default.
- W156808887 hasRelatedWork W2390728922 @default.
- W156808887 hasRelatedWork W2390890316 @default.
- W156808887 hasRelatedWork W2391214975 @default.
- W156808887 hasRelatedWork W2392932807 @default.
- W156808887 hasRelatedWork W2418699479 @default.
- W156808887 hasRelatedWork W2804245268 @default.
- W156808887 hasRelatedWork W2811128248 @default.
- W156808887 hasRelatedWork W3032230744 @default.
- W156808887 hasRelatedWork W2187813734 @default.
- W156808887 hasVolume "12" @default.
- W156808887 isParatext "false" @default.
- W156808887 isRetracted "false" @default.
- W156808887 magId "156808887" @default.
- W156808887 workType "article" @default.